• The Japanese company AnGes begins Phase I/II trials.
• The Indian company Bharat Biotech will begin Phase I/II trials.
• The Australian company Vaxine launched a Phase I trial.
• The American company Pfizer reported Phase I results.
• The American company Inovio announced interim Phase I results.
• A vaccine by CanSino Biologics was approved for military use.